NVO → $55.00 by Dec 9, 2026.

I wanted to share my thesis on Novo Nordisk (NVO) about why its a great investment at this price. I’m not a financial expert—just a long-term investor sharing my perspective. First of all, many people seems to be freaking out about the recent price cuts, but I actually think they could be very beneficial in the long run. The obesity market is enormous, and Wegovy—or whatever succeeds it—could remain a strong product even after patent expiration thanks to Novo's scale, …